Sotac Pharmaceuticals Limited (NSE:SOTAC)

Sotac Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	11.78	15.64	34.18	96.82	0.28
Short-Term Investments	-	4.59	4.33	4.12	-
Cash & Short-Term Investments	11.78	20.23	38.51	100.94	0.28
Cash Growth	-41.77%	-47.47%	-61.85%	36470.65%	-93.68%
Accounts Receivable	329.5	341.12	262.88	147.41	122.53
Other Receivables	-	0.02	-	3.22	0.55
Receivables	329.5	341.14	262.88	150.63	123.08
Inventory	270.77	202.61	180.1	136.42	53.95
Prepaid Expenses	-	2.15	1.39	0.55	0.11
Other Current Assets	164.74	132.14	123.58	82.85	81.35
Total Current Assets	776.79	698.27	606.45	471.39	258.76
Property, Plant & Equipment	474.81	469.71	387.19	240.5	87.94
Long-Term Investments	29.16	37.82	20.96	-	3.92
Goodwill	19.03	19.03	19.01	19.06	-
Other Intangible Assets	19.87	0.19	0.13	0.03	0.05
Long-Term Deferred Tax Assets	9.78	13.01	14.27	-	0.2
Other Long-Term Assets	5.25	5.25	5.25	5.25	1.66
Total Assets	1,335	1,243	1,053	736.39	352.54

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	271.92	189.44	288.94	253.94	197.42
Accrued Expenses	-	8.2	6.5	9.63	4.42
Short-Term Debt	272.09	187.51	98.75	108.24	51.86
Current Portion of Long-Term Debt	-	107.54	28.53	34.46	12.31
Current Income Taxes Payable	-	9.14	3.97	15.95	-
Other Current Liabilities	39.59	13.65	10.61	35.91	10.05
Total Current Liabilities	583.6	515.49	437.3	458.12	276.05
Long-Term Debt	103.88	141.94	121.31	77.69	9.7
Pension & Post-Retirement Benefits	1.51	1.63	1.37	0.96	0.56
Long-Term Deferred Tax Liabilities	-	-	-	2.77	-
Total Liabilities	688.99	659.06	559.98	539.54	286.32

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	110.5	110.5	110.5	80.5	23
Additional Paid-In Capital	-	280.23	280.22	-	-
Retained Earnings	-	139.07	58.81	16	-
Comprehensive Income & Other	478.25	2.73	3.06	98.1	43.22
Total Common Equity	588.75	532.52	452.59	194.59	66.22
Minority Interest	56.97	51.7	40.7	2.26	-
Shareholders' Equity	645.72	584.22	493.29	196.86	66.22
Total Liabilities & Equity	1,335	1,243	1,053	736.39	352.54

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	375.97	436.99	248.59	220.39	73.88
Net Cash (Debt)	-364.19	-416.76	-210.08	-119.45	-73.6
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-32.97	-37.72	-19.14	-14.84	-9.14
Filing Date Shares Outstanding	11.03	11.05	11.05	8.05	8.05
Total Common Shares Outstanding	11.03	11.05	11.05	8.05	8.05
Working Capital	193.2	182.78	169.15	13.27	-17.29
Book Value Per Share	53.39	48.19	40.96	24.17	8.23
Tangible Book Value	549.84	513.3	433.45	175.5	66.17
Tangible Book Value Per Share	49.86	46.45	39.23	21.80	8.22
Land	-	87.41	87.41	39.22	11.92
Buildings	-	165.42	89.61	82.7	30.2
Machinery	-	353.72	259.72	188.01	93.24
Construction In Progress	-	2.04	51.24	0.41	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error